Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human EHD2 Anticorps:
anti-Mouse (Murine) EHD2 Anticorps:
anti-Rat (Rattus) EHD2 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal EHD2 Primary Antibody pour ELISA, WB - ABIN250284
Guilherme, Soriano, Furcinitti, Czech: Role of EHD1 and EHBP1 in perinuclear sorting and insulin-regulated GLUT4 recycling in 3T3-L1 adipocytes. dans The Journal of biological chemistry 2004
Human Polyclonal EHD2 Primary Antibody pour IHC, IHC (p) - ABIN4307515
Kim, Kim, Jeon, Kim, Kim, Bae, Jung: Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma. dans PLoS ONE 2017
Our prognostic model is useful for predicting persistent/recurrent disease after surgery of Papillary thyroid carcinoma (PTC (Montrer F9 Anticorps)). EHD2 mRNA expression could be a novel prognostic marker for PTC (Montrer F9 Anticorps) patients.
EHD2 expression, along with the epithelial marker E-cadherin (Montrer CDH1 Anticorps), was markedly reduced in tumor tissues than in adjacent noncancerous tissues. Molecular data indicated that EHD2 inhibited migration and invasion of hepatocellular carcinoma probably by interacting with E-cadherin (Montrer CDH1 Anticorps).
Data suggest that the EH-domain containing 2 protein (EHD2) NPF phenylalanine residue is crucial for EHD2 localization to the plasma membrane, whereas the proline residue is essential for EHD2 dimerization and binding.
EHD2 can inhibit the metastasis of human breast cancer by regulating the epithelial-to-mesenchymal transition markers E-cadherin (Montrer CDH1 Anticorps) and N-cadherin (Montrer CDH2 Anticorps).
Downregulation of EHD2 was associated with migration and invasion by abrogating the expression of Rac1 in breast cancer patients.
Phosphatidylinositol 4,5-bisphosphate controls EHD2 plasma membrane localization.
Our results suggested that EHD2 low expression is involved in the pathogenesis of human esophageal squamous cell carcinoma
EHD2 participates in the sarcolemma repair.
Assembly of EHD2 stabilized and constrained caveolae to the plasma membrane to control turnover, and depletion of EHD2, resulting in endocytic and more dynamic and short-lived caveolae.
Among three EHD proteins (EHD1-EHD3 (Montrer EHD3 Anticorps)) that were tested, only EHD2 accumulates in the nucleus under nuclear export inhibition treatment.
EHD1 (Montrer EHD1 Anticorps), EHD2 (Montrer EHD3 Anticorps), and EHD4 (Montrer EHD4 Anticorps) are recruited to caveolae. Recruitment of the other EHDs increases markedly when EHD2 (Montrer EHD3 Anticorps), which has been previously detected at caveolae, is absent. Construction of knockout cell lines lacking EHDs 1, 2, and 4 confirms this apparent functional redundancy.
The regulatory N-terminal residues and the EH domain keep the EHD2 (Montrer EHD3 Anticorps) dimer in an autoinhibited conformation in solution. By significantly advancing the use of infrared reflection-absorption spectroscopy, we demonstrate that EHD2 (Montrer EHD3 Anticorps) adopts an open conformation by tilting the helical domains upon membrane binding.
The helical domain of EHD2 (Montrer EHD3 Anticorps) is inserted into the membrane.The N terminus domain regulates caveolar targeting of EHD2 (Montrer EHD3 Anticorps).
Assembly of EHD2 (Montrer EHD3 Anticorps) stabilized and constrained caveolae to the plasma membrane to control turnover, and depletion of EHD2 (Montrer EHD3 Anticorps), resulting in endocytic and more dynamic and short-lived caveolae.
The characterization of Fer1L5 and its interaction with EHD1 (Montrer EHD1 Anticorps) and EHD2 (Montrer EHD3 Anticorps) underscores the complex requirement of ferlin proteins and mediators of endocytic recycling for membrane trafficking events during myotube formation
appears to connect endocytosis to the actin cytoskeleton through interactions of its N-terminal domain with membranes and its C-terminal EH domain with the novel EHBP1 (Montrer EHBP1 Anticorps) protein
interaction of myoferlin (Montrer MYOF Anticorps) with EHD2 (Montrer EHD3 Anticorps) identifies molecular overlap between the endocytic recycling pathway and the machinery that regulates myoblast membrane fusion
This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway.
EH domain containing 2
, EH domain-containing protein 2
, PAST homolog 2
, putative eps protein
, EH-domain containing 2
, EH-domain containing 1
, EH-domain-containing protein 2
, EH domain-containing protein 2-like